| 臺大學術典藏 |
2022-09-15T01:09:06Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2022-09-15T01:08:47Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-03-15T03:29:02Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; TA-CHEN HUANG; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer
|
Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022 |
B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
|
Hsu C.-L.; Huang Y.-L.; Lin C.-C.; Huang T.-C.; Wu I.-C.; Lin C.-Y.; Lien M.-Y.; Kuo H.-Y.; Cheng A.-L.; CHIH-HUNG HSU; Guo J.-C. |
| 臺大學術典藏 |
2022 |
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma
|
CHIH-HUNG HSU; Cheng A.-L.; Lien M.-Y.; Kuo H.-Y.; Lin C.-Y.; Huang T.-C.; Hsu C.-L.; Lin C.-C.; Guo J.-C. |
| 臺大學術典藏 |
2021-08-18T07:39:05Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
JHE-CYUAN GUO; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-06-03T06:15:36Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F. |
| 臺大學術典藏 |
2021-04-27T08:36:01Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-04-27T08:11:50Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-10T05:34:17Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Ta-Chen Huang; Hsu C.-H. |
| 國立成功大學 |
2021 |
High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis
|
Lien, M.-Y.;Yeh, S.-P.;Gau, J.-P.;Wang, P.-N.;Li, S.-S.;Dai, M.-S.;Chen, T.C.;Hsieh, P.-Y.;Chiou, L.-W.;Huang, W.-H.;Liu, Y.-C.;Ko, B.-S.;(TBMTR), Taiwan Blood and Marrow Transplantation Registry |
| 臺大學術典藏 |
2020-12-28T08:14:14Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
Li H.-Y.; Fan S.-C.; Lin P.-H.; YEN-HSUAN NI; Chiu C.-F.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu C.-H.; Huang T.-C.; Shao Y.-Y.; Lien M.-Y.; Kuo H.-Y.; MIN-SHU HSIEH; Lin C.-Y.; Lin C.-C.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Lin C.-Y.;Min-Shu Hsieh;Kuo H.-Y.;Lien M.-Y.;Shao Y.-Y.;Huang T.-C.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu C.-H.; Huang T.-C.; Shao Y.-Y.; Lien M.-Y.; Kuo H.-Y.; MIN-SHU HSIEH; Lin C.-Y.; Lin C.-C.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Lin C.-Y.;Min-Shu Hsieh;Kuo H.-Y.;Lien M.-Y.;Shao Y.-Y.;Huang T.-C.;Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C; Chia-Chi Lin; Lin C.-Y; Hsieh M.-S; Kuo H.-Y; Lien M.-Y; Shao Y.-Y; Huang T.-C; Hsu C.-H. |
